Novartis' Blood Cancer Drug Meets Study Goal - Wall Street Journal
Novartis' Blood Cancer Drug Meets Study GoalWall Street JournalZURICH (Dow Jones)--Novartis AG (NVS) Tuesday said an experimental drug for the treatment of myelofibrosis, a rare form of blood cancer, met the goals of a late-stage study, which should pave the way to file the ...and more��
Blog Content
No comments:
Post a Comment